Handelsbanken Fonder’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-28,300
Closed -$218K 1534
2025
Q3
$218K Hold
28,300
﹤0.01% 1475
2025
Q2
$207K Hold
28,300
﹤0.01% 1489
2025
Q1
$269K Hold
28,300
﹤0.01% 1438
2024
Q4
$466K Buy
28,300
+3,100
+12% +$48.1K ﹤0.01% 1318
2024
Q3
$372K Buy
25,200
+2,700
+12% +$42.2K ﹤0.01% 1347
2024
Q2
$312K Buy
22,500
+2,600
+13% +$36.9K ﹤0.01% 1371
2024
Q1
$313K Hold
19,900
﹤0.01% 1369
2023
Q4
$322K Buy
19,900
+1,300
+7% +$21.3K ﹤0.01% 1362
2023
Q3
$229K Hold
18,600
﹤0.01% 1414
2023
Q2
$299K Buy
18,600
+1,800
+11% +$29.7K ﹤0.01% 1352
2023
Q1
$292K Hold
16,800
﹤0.01% 1307
2022
Q4
$155K Hold
16,800
﹤0.01% 1470
2022
Q3
$145K Hold
16,800
﹤0.01% 1483
2022
Q2
$137K Hold
16,800
﹤0.01% 1550
2022
Q1
$204K Sell
16,800
-4,000
-19% -$84.2K ﹤0.01% 1630
2021
Q4
$710K Hold
20,800
﹤0.01% 1107
2021
Q3
$1M Hold
20,800
0.01% 902
2021
Q2
$940K Sell
20,800
-1,200
-5% -$53.2K ﹤0.01% 960
2021
Q1
$1.06M Hold
22,000
0.01% 810
2020
Q4
$1.18M Hold
22,000
0.01% 752
2020
Q3
$812K Hold
22,000
0.01% 795
2020
Q2
$682K Buy
+22,000
New +$610K 0.01% 820

Other funds holding NEO

Handelsbanken Fonder's NEO Position: Q4 2025 in Review

Handelsbanken Fonder sold out of NeoGenomics (NEO) in Q4 2025, closing a stake of 28,300 shares — an estimated $218K sold.

Handelsbanken Fonder first reported a position in NEO in Q2 2020 and held it in 22 quarters. The position peaked at $1.18M in Q4 2020. 256 funds tracked by Wall St. Rank hold NEO as of Q4 2025.

  • Handelsbanken Fonder reported no remaining NeoGenomics position as of Q4 2025 after selling out during the quarter.
  • Handelsbanken Fonder sold 28,300 NeoGenomics shares in Q4 2025, an estimated $218K.
  • Handelsbanken Fonder first reported a position in NeoGenomics in Q2 2020 and held it in 22 quarters.
  • Handelsbanken Fonder's NeoGenomics position peaked at $1.18M in Q4 2020.
  • 256 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2025.

Based on Handelsbanken Fonder's 13F filing for Q4 2025, filed 6 Feb 2026.